Towards Healthcare
Europe Central Lab Market to Reach USD 1507 Mn by 2034

Europe Central Lab Market Rising on Clinical Trials Surge

Market insights predict, the Europe central lab industry is expected to grow from USD 865 million in 2024 to USD 1507 million by 2034, driven by a CAGR of 5.71%. The market is growing due to rising clinical trial volumes, precision medicine adoption, and increased outsourcing by pharmaceutical companies.  Western Europe dominates the market owing to a strong regulatory framework, advanced laboratory infrastructure, and growing biopharmaceutical research activities.

  • Insight Code: 6290
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The Europe central lab market stands at USD 914 million in 2025 and is expected to reach USD 1507 million by 2034, growing at a CAGR of 5.71% from 2024 to 2034.

Western Europe is currently leading the Europe central lab market due to its robust network of independent and reference laboratories, high demand for specialized diagnostic and analytical services, and growing focus on precision medicine.

CIRION BioPharma Research, Frontage Laboratories, Quest Diagnostics, Charles River Laboratories, Sonic Healthcare, Unilabs, SCM BIOGROUP 

Services include biomarker testing, genetic and genomic analysis, sample management, pharmacokinetics, bioanalytics, and support for drug development and cell/gene therapies.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.